These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10362262)

  • 21. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation.
    Sawasdikosol S; Chang JH; Pratt JC; Wolf G; Shoelson SE; Burakoff SJ
    J Immunol; 1996 Jul; 157(1):110-6. PubMed ID: 8683103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-Cbl, the Drosophila homologue of the c-Cbl proto-oncogene, interacts with the Drosophila EGF receptor in vivo, despite lacking C-terminal adaptor binding sites.
    Hime GR; Dhungat MP; Ng A; Bowtell DD
    Oncogene; 1997 Jun; 14(22):2709-19. PubMed ID: 9178769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane-anchored Cbl suppresses Hck protein-tyrosine kinase mediated cellular transformation.
    Howlett CJ; Robbins SM
    Oncogene; 2002 Mar; 21(11):1707-16. PubMed ID: 11896602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two distinct pools of Src family tyrosine kinases regulate PDGF-induced DNA synthesis and actin dorsal ruffles.
    Veracini L; Franco M; Boureux A; Simon V; Roche S; Benistant C
    J Cell Sci; 2006 Jul; 119(Pt 14):2921-34. PubMed ID: 16787943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl.
    Yoon CH; Lee J; Jongeward GD; Sternberg PW
    Science; 1995 Aug; 269(5227):1102-5. PubMed ID: 7652556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cbl oncogene: a novel substrate of protein tyrosine kinases.
    Langdon WY
    Aust N Z J Med; 1995 Dec; 25(6):859-64. PubMed ID: 8770364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The signal transduction through Grb2/Ash in hematopoietic cells.
    Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
    Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.
    Yokote K; Hellman U; Ekman S; Saito Y; Rönnstrand L; Saito Y; Heldin CH; Mori S
    Oncogene; 1998 Mar; 16(10):1229-39. PubMed ID: 9546424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Src family kinases negatively regulate platelet-derived growth factor alpha receptor-dependent signaling and disease progression.
    Rosenkranz S; Ikuno Y; Leong FL; Klinghoffer RA; Miyake S; Band H; Kazlauskas A
    J Biol Chem; 2000 Mar; 275(13):9620-7. PubMed ID: 10734113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice.
    Murphy MA; Schnall RG; Venter DJ; Barnett L; Bertoncello I; Thien CB; Langdon WY; Bowtell DD
    Mol Cell Biol; 1998 Aug; 18(8):4872-82. PubMed ID: 9671496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative regulation of receptor tyrosine kinases: unexpected links to c-Cbl and receptor ubiquitylation.
    Rubin C; Gur G; Yarden Y
    Cell Res; 2005 Jan; 15(1):66-71. PubMed ID: 15686631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases.
    Roche S; Koegl M; Barone MV; Roussel MF; Courtneidge SA
    Mol Cell Biol; 1995 Feb; 15(2):1102-9. PubMed ID: 7823926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated Cdc42 sequesters c-Cbl and prevents EGF receptor degradation.
    Wu WJ; Tu S; Cerione RA
    Cell; 2003 Sep; 114(6):715-25. PubMed ID: 14505571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of function Cbl-c mutations in solid tumors.
    Daniels SR; Liyasova M; Kales SC; Nau MM; Ryan PE; Green JE; Lipkowitz S
    PLoS One; 2019; 14(7):e0219143. PubMed ID: 31260484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function.
    Li Z; Dong T; Pröschel C; Noble M
    PLoS Biol; 2007 Feb; 5(2):e35. PubMed ID: 17298174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction.
    Lupher ML; Rao N; Eck MJ; Band H
    Immunol Today; 1999 Aug; 20(8):375-82. PubMed ID: 10431158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation.
    Mosesson Y; Shtiegman K; Katz M; Zwang Y; Vereb G; Szollosi J; Yarden Y
    J Biol Chem; 2003 Jun; 278(24):21323-6. PubMed ID: 12719435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors.
    Franco M; Furstoss O; Simon V; Benistant C; Hong WJ; Roche S
    Mol Cell Biol; 2006 Mar; 26(5):1932-47. PubMed ID: 16479011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion.
    Fournier TM; Lamorte L; Maroun CR; Lupher M; Band H; Langdon W; Park M
    Mol Biol Cell; 2000 Oct; 11(10):3397-410. PubMed ID: 11029044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.